相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cost-Effectiveness of Using Pharmacogenetic Information in Warfarin Dosing for Patients With Nonvalvular Atrial Fibrillation
Mark H. Eckman et al.
ANNALS OF INTERNAL MEDICINE (2009)
The largest prospective warfarin-treated cohort supports genetic forecasting
Mia Wadelius et al.
BLOOD (2009)
Genetic Testing Before Anticoagulation? A Systematic Review of Pharmacogenetic Dosing of Warfarin
Kirsten Neudoerffer Kangelaris et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2009)
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
Fumihiko Takeuchi et al.
PLOS GENETICS (2009)
Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins
Tom Schalekamp et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
CYP4F2 genetic variant alters required warfarin dose
Michael D. Caldwell et al.
BLOOD (2008)
Pharmacology and management of the vitamin K antagonists
Jack Ansell et al.
CHEST (2008)
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin
B. F. Gage et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Pharmacogenetics of Warfarin: Development of a Dosing Algorithm for Brazilian Patients
J. A. Perini et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Dosing algorithms to predict warfarin maintenance dose in Caucasians and African Americans
H. Schelleman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Rapid typing of STRs in the human genome by HyBeacon (R) melting
Nittaya Gale et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2008)
CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation:: A prospective randomized controlled study
Y. Caraco et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation
Jeffrey L. Anderson et al.
CIRCULATION (2007)
Coumarin anticoagulants and co-trimoxazole: avoid the combination rather than manage the interaction
Tom Schalekamp et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2007)
VKORC1 and CYP2C9 genotypes and phenprocoumon anticoagulation status:: interaction between both genotypes affects dose requirement
T. Schalekamp et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Pharmacogenetics of warfarin: current status and future challenges
M. Wadelius et al.
PHARMACOGENOMICS JOURNAL (2007)
Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose:: a prospective study
John F. Carlquist et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2006)
A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P4502C9
Lai-San Tham et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
VKORC1 and CYP2C9 genotypes and acenocoumarol anticoagulation status:: Interaction between both genotypes affects overanticoagulation
Tom Schalekamp et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements:: proposal for a new dosing regimen
EA Sconce et al.
BLOOD (2005)
A C1173T dimorphism in the VKORC1 gene determines coumarin Sensitivity and bleeding risk
PH Reitsma et al.
PLOS MEDICINE (2005)
Prospective, Randomized Pilot Trial of Model-Based Warfarin Dose Initiation using CYP2C9 Genotype and Clinical Data
Michael A. Hillman et al.
CLINICAL MEDICINE & RESEARCH (2005)
Cytochrome P4502C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity
L Bodin et al.
BLOOD (2005)
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients
S Schulman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Common VKORC1 and GGCX polymorphisms associated with warfarin dose
M Wadelius et al.
PHARMACOGENOMICS JOURNAL (2005)
A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin
G D'Andrea et al.
BLOOD (2005)
Effects of cytochrome P4502C9 polymorphisms on phenprocoumon anticoagulation status
T Schalekamp et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Acenocoumarol stabilization is delayed in CYP2C9*3 carriers
T Schalekamp et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Low rate of bleeding and thrombotic complications of oral anticoagulant therapy independent of age in the real-practice of an anticoagulation clinic
D Poli et al.
BLOOD COAGULATION & FIBRINOLYSIS (2003)
Oral anticoagulation and risk of death:: a medical record linkage study
A Odén et al.
BMJ-BRITISH MEDICAL JOURNAL (2002)
Ultra-rapid DNA analysis using HyBeacon™ probes and direct PCR amplification from saliva
DJ French et al.
MOLECULAR AND CELLULAR PROBES (2002)
Lifestyle and diet as risk factors for overanticoagulation
FJA Penning-van Beest et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2002)
HyBeacon™ probes:: a new tool for DNA sequence detection and allele discrimination
DJ French et al.
MOLECULAR AND CELLULAR PROBES (2001)
Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation
EM Hylck et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
分享论文
